144 related articles for article (PubMed ID: 28012178)
1. Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study.
Oh CC; Hofbauer GFL; Serra AL; Harwood CA; Mitchell L; Proby CM; Olasz EB; Mosel DD; Piaserico S; Fortina AB; Geusau A; Jahn-Bassler K; Gerritsen MJP; Seçkin D; Güleç AT; Cetkovská P; Ricar J; Imko-Walczuk B; Dębska-Ślizień A; Bouwes Bavinck JN
Br J Dermatol; 2017 May; 176(5):1179-1186. PubMed ID: 28012178
[TBL] [Abstract][Full Text] [Related]
2. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
[TBL] [Abstract][Full Text] [Related]
3. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.
Hameetman L; Commandeur S; Bavinck JN; Wisgerhof HC; de Gruijl FR; Willemze R; Mullenders L; Tensen CP; Vrieling H
BMC Cancer; 2013 Feb; 13():58. PubMed ID: 23379751
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Types of Genital Lesions in Organ Transplant Recipients.
Nadhan KS; Larijani M; Abbott J; Doyle AM; Linfante AW; Chung CL
JAMA Dermatol; 2018 Mar; 154(3):323-329. PubMed ID: 29387873
[TBL] [Abstract][Full Text] [Related]
6. Pronounced allelic imbalance at D9S162 in skin squamous cell carcinoma of organ transplant recipients.
Mühleisen B; Petrov I; Frigerio S; Dziunycz P; French LE; Hofbauer GF
Arch Dermatol; 2012 Jun; 148(6):697-703. PubMed ID: 22508773
[TBL] [Abstract][Full Text] [Related]
7. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
9. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
11. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs).
Reichrath J; Nürnberg B
Adv Exp Med Biol; 2008; 624():203-14. PubMed ID: 18348458
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of squamous cell carcinoma in organ transplant recipients.
Stasko T; Brown MD; Carucci JA; Euvrard S; Johnson TM; Sengelmann RD; Stockfleth E; Tope WD; ;
Dermatol Surg; 2004 Apr; 30(4 Pt 2):642-50. PubMed ID: 15061849
[TBL] [Abstract][Full Text] [Related]
13. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
14. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.
Lindelöf B; Dal H; Wolk K; Malmborg N
Arch Dermatol; 2005 Apr; 141(4):447-51. PubMed ID: 15837862
[TBL] [Abstract][Full Text] [Related]
16. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
[TBL] [Abstract][Full Text] [Related]
17. Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study.
Bouwes Bavinck JN; Harwood CA; Genders RE; Wisgerhof HC; Plasmeijer EI; Mitchell L; Olasz EB; Mosel DD; Pokorney MS; Serra AL; Feldmeyer L; Baumann Conzett K; Piaserico S; Belloni Fortina A; Jahn K; Geusau A; Gerritsen MJ; Seckin D; Gulec AT; Cetkovska P; Ricar J; Imko-Walczuk B; Proby CM; Hofbauer GF
Am J Transplant; 2014 Mar; 14(3):668-76. PubMed ID: 24730051
[TBL] [Abstract][Full Text] [Related]
18. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
[TBL] [Abstract][Full Text] [Related]
19. Field Therapy in Solid Organ Transplant Recipients: Are We Initiating Early Enough?
Topham C; Haynes D; Hopkins RS; Leitenberger J
J Drugs Dermatol; 2020 Mar; 19(3):335-336. PubMed ID: 32550695
[TBL] [Abstract][Full Text] [Related]
20. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
